St. Jude Medical Initiates Landmark Study Of Renal Denervation For Reduction Of Heart Attack, Stroke And Death

EnligHTNment trial will evaluate whether patients with hypertension that are treated with renal denervation and medication experience additional benefits beyond a reduction in blood pressure St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced plans for a new landmark study that will evaluate whether renal denervation and medication can provide health benefits to patients beyond lowering high blood pressure...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Heart Disease Source Type: news